.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Cantor Fitzgerald
Queensland Health
Moodys
Chubb
UBS
US Army
Fish and Richardson
Colorcon

Generated: December 18, 2017

DrugPatentWatch Database Preview

Bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride and what is the scope of bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride freedom to operate?

Bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
is the generic ingredient in two branded drugs marketed by Braintree and Novel Labs Inc, and is included in two NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. One supplier is listed for this compound.

Summary for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs IncPEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYLbisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chlorideFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL202217-001Aug 20, 2014RXNoYes► Subscribe► Subscribe► Subscribe
BraintreeHALFLYTELYbisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chlorideFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL021551-003Jul 16, 2010DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
QuintilesIMS
Federal Trade Commission
Colorcon
Deloitte
Moodys
Boehringer Ingelheim
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot